SCHEMBL2837080

SCHEMBL2837080

CN1CCC(Oc2ccc(Cl)c3ccccc23)c2sccc2C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.38
NPSR1 Q6W5P4 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
TSHR P16473 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33
NOS2 P35228 1/20 0.33
ALDH1A1 P00352 1/20 0.33
DRD1 P21728 3/20 0.33
DRD2 P14416 2/20 0.33
DRD4 P21917 2/20 0.33
DRD5 P21918 2/20 0.33
DRD3 P35462 2/20 0.33
HTR2A P28223 4/20 0.32
SLC6A4 P31645 2/20 0.32
HTR2B P41595 2/20 0.32
THRB P10828 1/20 0.32
NR1I2 O75469 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2841003 0.99 POLB (0.37) POLBNPSR1TDP1TSHRNPC1
SCHEMBL2841728 0.78 KDM4E (0.40) ALDH1A1DRD2HTR2ASLC6A4KCNH2
Hydrochloric Acid SCHEMBL2845761 0.77 KDM4E (0.40) ALDH1A1SLC6A4KCNH2SLC6A2SLC6A3
SCHEMBL2842497 0.75 SLC6A2 (0.38) NOS3NOS1NOS2ALDH1A1SLC6A4
Hydrochloric Acid SCHEMBL2836930 0.73 TP53 (0.34) POLBTSHRALDH1A1SLC6A4OPRK1
SCHEMBL2835227 0.72 SLC6A2 (0.42) TSHRSLC6A4SLC6A2SLC6A3
Hydrochloric Acid SCHEMBL2840985 0.71 MEN1 (0.42) TSHRSLC6A4SLC6A2SLC6A3
SCHEMBL2837935 0.71 DRD2 (0.38) DRD1DRD2DRD4DRD5DRD3
SCHEMBL2841182 0.70 SLC6A2 (0.37) NPC1RAB9AALDH1A1DRD2DRD3
Hydrochloric Acid SCHEMBL2844346 0.70 MEN1 (0.32) DRD1DRD2DRD4DRD5DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US claimed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP claimed
US-8217031-B2 Heteroaryl derivatives NIPPON SHINYAKU CO., LTD. (JP) 2012-07-10 US disclosed
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US disclosed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048537-A1 HETEROARYL DERIVATIVES OPRD1, OPRM1, OPRK1 POLB 3087/4885NPSR1 13/4885TDP1 3509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.